Quantcast

Latest Alere Inc. Stories

2014-09-02 20:24:43

WALTHAM, Mass., Sept. 2, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B). The dividend is payable on October 15, 2014 to holders of record of Series B stock at the close of business on October 1, 2014. Such payment will cover the amount of all dividends accrued from July 1, 2014 through...

2014-08-08 08:26:14

WALTHAM, Mass., Aug. 8, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today that it will attend the Canaccord Genuity 34(th) Annual Growth Conference to be held on August 13-14, 2014 at the InterContinental Hotel in Boston. Jon Russell, Vice President, Finance, will attend the conference. Mr. Russell's presentation is scheduled for Wednesday, August 13, at 10:00 am ET. About Alere Alere's global leading rapid diagnostic products and...

2014-08-04 08:27:18

WALTHAM, Mass., Aug. 4, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today announced its financial results for the quarter ended June 30, 2014. Namal Nawana, Interim Chief Executive Officer and Chief Operating Officer of Alere said, "The second quarter was a period of significant transition for Alere. With the recently announced change in leadership, we are now narrowing our focus on our global leading rapid diagnostic...

2014-07-28 12:28:16

DALLAS, July 28, 2014 /PRNewswire/ -- The In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017 research report says global industry is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The global in vitro diagnostics market...

2014-07-25 12:25:08

WALTHAM, Mass., July 25, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today announced that it will release its second quarter 2014 earnings on Monday, August 4, 2014. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and...

2014-07-14 08:27:10

Results Published Ahead of Print in the Journal of Acquired Immune Deficiency Syndromes (JAIDS) WALTHAM, Mass., July 14, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced the publication of a study demonstrating the viability of accurate and rapid HIV screening among infants at the point of care (POC). The study was conducted in five clinics in Maputo, Mozambique, with the prototype of Alere's new POC nucleic acid test, the Alere(TM) q HIV-1/2 Detect assay. Results of the...

2014-07-01 08:29:16

Ron Zwanziger Resigns as Chief Executive Officer and President; Namal Nawana Appointed Interim CEO WALTHAM, Mass., July 1, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, today announced as part of its ongoing review of its strategy and operations, that Chief Operating Officer Namal Nawana has been...

2014-06-23 12:29:10

LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Enteric Disease Testing Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/diagnostics/global_enteric_disease_testing_market_2014_2018.html TechNavio's analysts forecast the Global Enteric Disease Testing market to grow at a CAGR of 2.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of enteric...

2014-06-18 12:35:49

WALTHAM, Mass., June 18, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced that it has elected not to proceed at this time with its previously announced plans to pursue an initial public offering in the United Kingdom of the ordinary shares of BBI Diagnostics Group plc, or BBI Diagnostics, and intends to seek greater value for the businesses of BBI Diagnostics than could be realized under current equity market conditions in the United Kingdom. Alere remains committed to its...

2014-06-16 08:29:05

First-ever Platform to Deliver Highly Accurate, Molecular Results in Under 15 Minutes WALTHAM, Mass., June 16, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostic and health information solutions, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Alere(TM) i Influenza A & B test, the first and only molecular test to detect and differentiate influenza A and B virus in less...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'